2012
DOI: 10.1128/cvi.05414-11
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
49
0
9

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(61 citation statements)
references
References 42 publications
3
49
0
9
Order By: Relevance
“…Prophylactic and therapeutic protocols were used, by subcutaneous vaccination of P10-primed DCs before infection, and by subcutaneous or intravenous vaccination weeks after infection. 16 Immunization with P10-primed DCs induced the production of IFN-γ and IL-12 with low IL-10 and IL-4, simultaneously with reduced fungal load and low tissue damage. Potentially, this kind of immunization may confer rapid protection against serious cases of PCM and successfully treat established disease.…”
Section: Disclosure Of Potential Conflicts Of Interestmentioning
confidence: 98%
“…Prophylactic and therapeutic protocols were used, by subcutaneous vaccination of P10-primed DCs before infection, and by subcutaneous or intravenous vaccination weeks after infection. 16 Immunization with P10-primed DCs induced the production of IFN-γ and IL-12 with low IL-10 and IL-4, simultaneously with reduced fungal load and low tissue damage. Potentially, this kind of immunization may confer rapid protection against serious cases of PCM and successfully treat established disease.…”
Section: Disclosure Of Potential Conflicts Of Interestmentioning
confidence: 98%
“…When bone marrow DCs pulsed with P10 were given subcutaneously to naïve mice that were subsequently infected with P. brasiliensis yeasts, researchers found an 2-log decrease in fungal burden in immunized mice compared with control groups. This strategy was also successful in decreasing fungal burdens in the lungs of mice infected 30 days before therapy, suggesting that this strategy can be therapeutic as well as prophylactic (Magalhaes et al 2012).…”
Section: Fungal Vaccines and Immunotherapeuticsmentioning
confidence: 86%
“…Portanto, a identificação e caracterização das mesmas podem contribuir para o entendimento dos mecanismos de patogenicidade nos casos da conidiobolomicose ovina, bem como na utilização para diagnósticos sorológicos ou como candidatos a vacinas. Estudos conduzidos em fungos patogênicos de importância biomédica já permitiram obter importantes informações sobre proteínas imunogênicas com papel fundamental no processo de invasão, sobrevivência no hospedeiro e como possíveis candidatos a vacina (Camargo et al 1989, Krajaejun et al 2006, Chindamporn et al 2009, Perenha-Viana et al 2012, Magalhães et al 2012.…”
Section: Discussionunclassified